Who Can Participate?
Adults 18-70 with atopic dermatitis (AD) may participate.
Inclusion Criteria
• Diagnosis of AD for at least 12 months
• AD present on ≥10% BSA (body surface area)*
• Have had an inadequate response to topical medications within the past 6 months, or an intolerance to topical therapy
• Have not been treated with biologics
* 1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers).
What Are The Benefits?
• No cost to participate or receive treatment
• Regular visits with study doctors who specialise in treating AD (19 visits)
• Will receive a subcutaneous injection of the investigative treatment (study drug) or a placebo
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• 56-59 weeks
Note: Participants may not donate blood for the duration of the study.
If interested, please contact our Research Coordinator at 416-633-0001 x 4 or e-mail [email protected].
